Stournaras claims political motives behind Novartis scandal allegations


During his testimony at the trial of the two former protected witnesses in the Novartis case, Governor of the Bank of Greece Yannis Stournaras stated that he was implicated in the scandal for political reasons.

Stournaras had been accused by the witnesses of receiving bribes from Novartis while serving as finance minister, through companies owned by his wife, charges that were dismissed before going to trial.

Stournaras attributed the allegations of the protected witnesses Philistor Destampasidis and Maria Marangelis to political motives, hinting that SYRIZA was behind them.

“SYRIZA did not accept me later as Governor of the Bank of Greece. They believed that if they had one of their own in my position, they could do other things,” he said, adding that they weaponized inspections against his wife’s companies.

He said that he believes the witnesses were blackmailed into making these accusations against him.

“I believe they had caught the protected witnesses for unjustified enrichment or tax evasion and fabricated this story. They set up the Novartis conspiracy,” he said.

“Let them tell us who made them do it. I know very well, but I won’t tell you. I even know where the witness statements were written, they were copy-pasted,” Stournaras added. 

The trial of former protected witnesses in the high-profile Novartis bribery case, now facing charges of perjury and false accusations against prominent political figures, opened in April. 

At the center of the case are two pivotal figures in the long-running scandal, “Ekaterini Kelesi” and “Maximos Sarafis,” code names used during their time as protected witnesses.

In October, their protected status was revoked following a decision by Greek prosecutors, clearing the way for legal action to be taken against them by the politicians they had implicated.

The Novartis case, launched in 2017, alleged that several top Greek officials accepted bribes from the Swiss pharmaceutical giant in exchange for favorable treatment and market access, particularly during Greece’s financial crisis.





Source link